ResMed, Inc. (RMD)
240.33
+4.57
(+1.94%)
USD |
NYSE |
Aug 28, 16:00
240.31
-0.02
(-0.01%)
After-Hours: 20:00
ResMed Cash from Operations (Quarterly) : 454.63M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 454.63M |
| March 31, 2026 | 554.13M |
| December 31, 2025 | 339.74M |
| September 30, 2025 | 457.32M |
| June 30, 2025 | 538.77M |
| March 31, 2025 | 578.66M |
| December 31, 2024 | 308.62M |
| September 30, 2024 | 325.54M |
| June 30, 2024 | 440.11M |
| March 31, 2024 | 402.03M |
| December 31, 2023 | 272.83M |
| September 30, 2023 | 286.28M |
| June 30, 2023 | 237.44M |
| March 31, 2023 | 282.56M |
| December 31, 2022 | 128.64M |
| September 30, 2022 | 44.66M |
| June 30, 2022 | 79.49M |
| March 31, 2022 | 117.44M |
| December 31, 2021 | 219.88M |
| September 30, 2021 | -65.66M |
| June 30, 2021 | 226.52M |
| March 31, 2021 | 196.28M |
| December 31, 2020 | 169.92M |
| September 30, 2020 | 144.00M |
| June 30, 2020 | 330.26M |
| Date | Value |
|---|---|
| March 31, 2020 | 239.70M |
| December 31, 2019 | 69.93M |
| September 30, 2019 | 162.36M |
| June 30, 2019 | 141.82M |
| March 31, 2019 | 139.65M |
| December 31, 2018 | 129.47M |
| September 30, 2018 | 48.12M |
| June 30, 2018 | 129.42M |
| March 31, 2018 | 149.08M |
| December 31, 2017 | 132.55M |
| September 30, 2017 | 93.98M |
| June 30, 2017 | 140.31M |
| March 31, 2017 | 67.60M |
| December 31, 2016 | 119.90M |
| September 30, 2016 | 86.24M |
| June 30, 2016 | 142.96M |
| March 31, 2016 | 124.75M |
| December 31, 2015 | 158.15M |
| September 30, 2015 | 122.07M |
| June 30, 2015 | 99.70M |
| March 31, 2015 | 90.94M |
| December 31, 2014 | 106.00M |
| September 30, 2014 | 86.54M |
| June 30, 2014 | 115.58M |
| March 31, 2014 | 101.10M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Koninklijke Philips NV | 439.52M |
| Accuray, Inc. | 2.427M |
| Micron Solutions, Inc. | -- |
| Medtronic Plc | 2.573B |
| Orthofix Medical, Inc. | -6.147M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -383.65M |
| Cash from Financing (Quarterly) | -263.16M |
| Free Cash Flow | 1.629B |
| Free Cash Flow Per Share (Quarterly) | 2.741 |
| Free Cash Flow to Equity (Quarterly) | 414.63M |
| Free Cash Flow to Firm (Quarterly) | 397.38M |
| Free Cash Flow Yield | 4.64% |